OpenURL Connection Search

Select item for more details and to access through your institution.

Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.
Published in:
Human Reproduction, 2014, v. 29, n. 3, p. 525, doi. 10.1093/humrep/det430
By:
- van der Kaaij, M.A.E.;
- van Echten-Arends, J.;
- Heutte, N.;
- Meijnders, P.;
- Abeilard-Lemoisson, E.;
- Spina, M.;
- Moser, E.C.;
- Allgeier, A.;
- Meulemans, B.;
- Lugtenburg, P.J.;
- Aleman, B.M.P.;
- Noordijk, E.M.;
- Fermé, C.;
- Thomas, J.;
- Stamatoullas, A.;
- Fruchart, C.;
- Eghbali, H.;
- Brice, P.;
- Smit, W.G.J.M.;
- Sebban, C.
Publication type:
Article
EARLY FDG‐PET ADAPTED TREATMENT OF LIMITED STAGE HODGKIN LYMPHOMA (HL): 10Y LONG TERM FOLLOW‐UP ANALYSIS OF THE RANDOMIZED INTERGROUP EORTC/LYSA/FIL H10 TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 159, doi. 10.1002/hon.3163_105
By:
- Federico, M.;
- Fortpied, C.;
- Stepanishyna, Y.;
- Gotti, M.;
- van der Maazen, R.;
- Amorin, S.;
- Re, A.;
- Plattel, W.;
- Lazarovici, J.;
- Merli, F.;
- Specht, L.;
- de Colella, J. S.;
- Hutchings, M.;
- Versari, A.;
- Edeline, V.;
- Stamatoulas, A.;
- Girinsky, T.;
- Ricardi, U.;
- Aleman, B.;
- Meulemans, B.
Publication type:
Article
Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056)
Published in:
British Journal of Dermatology, 2012, v. 167, n. 3, p. 678, doi. 10.1111/j.1365-2133.2012.11156.x
By:
- Whittaker, S.;
- Ortiz, P.;
- Dummer, R.;
- Ranki, A.;
- Hasan, B.;
- Meulemans, B.;
- Gellrich, S.;
- Knobler, R.;
- Stadler, R.;
- Karrasch, M.
Publication type:
Article

Found: 3

Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.

EARLY FDG‐PET ADAPTED TREATMENT OF LIMITED STAGE HODGKIN LYMPHOMA (HL): 10Y LONG TERM FOLLOW‐UP ANALYSIS OF THE RANDOMIZED INTERGROUP EORTC/LYSA/FIL H10 TRIAL.

Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056)